APA (7th ed.) Citation

J, Z., L, X., Y, M., S, Q., R, Z., H, T., . . . J, L. (2025). Efficacy and safety of orelabrutinib combined with rituximab and high dose methotrexate in primary or secondary central nervous system diffuse large B-cell lymphoma: A retrospective analysis. Investigational new drugs, 43(3), 451. https://doi.org/10.1007/s10637-025-01542-7

Chicago Style (17th ed.) Citation

J, Zhou, et al. "Efficacy and Safety of Orelabrutinib Combined with Rituximab and High Dose Methotrexate in Primary or Secondary Central Nervous System Diffuse Large B-cell Lymphoma: A Retrospective Analysis." Investigational New Drugs 43, no. 3 (2025): 451. https://doi.org/10.1007/s10637-025-01542-7.

MLA (9th ed.) Citation

J, Zhou, et al. "Efficacy and Safety of Orelabrutinib Combined with Rituximab and High Dose Methotrexate in Primary or Secondary Central Nervous System Diffuse Large B-cell Lymphoma: A Retrospective Analysis." Investigational New Drugs, vol. 43, no. 3, 2025, p. 451, https://doi.org/10.1007/s10637-025-01542-7.